Literature DB >> 4629258

Human immunoglobulin specificity after group B arbovirus infections.

R M Scott, J M McCown, P K Russell.   

Abstract

Sera obtained during a dengue-2 epidemic from individuals with primary or secondary group B arbovirus infections contained cross-reactive antibody against several viruses in this group. Hemagglutination-inhibition antibody titers of the immunoglobulin M fractions from these sera revealed a rise in antibody specific for dengue-2. The acute and convalescent sera in over half of the secondary infection group also had low-level unchanging immunoglobulin M antibody titers to yellow fever which implicated yellow fever immunization as the primary infection.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4629258      PMCID： PMC422528          DOI： 10.1128/iai.6.3.277-281.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  17 in total

1.  Differentiation of cross-reacting simian cytomegalovirus strains by late 19S rabbit neutralizing antibodies.

Authors:  B Hampar; L M Martos; D V Ablashi; R F Siguënza; G A Wells
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

2.  The immune response to influenza virus. 3. Changes in the avidity and specificity of early IgM and IgG antibodies.

Authors:  R G Webster
Journal:  Immunology       Date:  1968-01       Impact factor: 7.397

3.  Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells.

Authors:  T M Yuill; P Sukhavachana; A Nisalak; P K Russell
Journal:  Am J Trop Med Hyg       Date:  1968-05       Impact factor: 2.345

4.  Greater specificity of 19S than 7S antibodies on haemagglutination-inhibition tests with closely related group B arboviruses.

Authors:  E G Westaway
Journal:  Nature       Date:  1968-07-06       Impact factor: 49.962

5.  Antibody responses in rabbits to the group B arbovirus Kumjin: serologic activity of the fractionated immunoglobulins in homologous and heterologous reactions.

Authors:  E G Westaway
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

6.  Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome.

Authors:  P K Russell; A Intavivat; S Kanchanapilant
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

7.  Dengue virus identification by the plaque reduction neutralization test.

Authors:  P K Russell; A Nisalak
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

8.  Antibody response in dengue and dengue hemorrhagic fever.

Authors:  P K Russell; S Udomsakdi; S B Halstead
Journal:  Jpn J Med Sci Biol       Date:  1967-12

9.  Heterotypic serologic responses after yellow fever vaccination; detection of persons with past St. Louis encephalitis or dengue.

Authors:  W L Pond; N J Ehrenkranz; J X Danauskas; M J Carter
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

10.  A plaque reduction test for dengue virus neutralizing antibodies.

Authors:  P K Russell; A Nisalak; P Sukhavachana; S Vivona
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422
View more
  10 in total

1.  Immune response in rabbits to virion and nonvirion antigens of the Flavivirus kunjin.

Authors:  A J Della-Porta; E G Westaway
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

2.  Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses.

Authors:  C H Calisher; A O el-Kafrawi; M I Al-Deen Mahmud; A P Travassos da Rosa; C R Bartz; M Brummer-Korvenkontio; S Haksohusodo; W Suharyono
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Factors influencing dengue virus isolation by C6/36 cell culture and mosquito inoculation of nested PCR-positive clinical samples.

Authors:  Richard G Jarman; Ananda Nisalak; Kathryn B Anderson; Chonticha Klungthong; Butsaya Thaisomboonsuk; Winai Kaneechit; Siripen Kalayanarooj; Robert V Gibbons
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

4.  Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.

Authors:  B Falgout; M Bray; J J Schlesinger; C J Lai
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Enzyme-linked immunosorbent assay (ELISA) for detection of specific IgA antibodies to mumps virus.

Authors:  B Halevy; I Sarov
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

6.  Immunoglobulin G- and M-specific enzyme-linked immunosorbent assay for detection of dengue antibodies.

Authors:  D Dittmar; T J Cleary; A Castro
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

7.  Solid-phase radioimmunoassay for antibodies to flavivirus structural and nonstructural proteins.

Authors:  D W Trent; C L Harvey; A Qureshi; D LeStourgeon
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

8.  Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients.

Authors:  W H Bancroft; F H Top; K H Eckels; J H Anderson; J M McCown; P K Russell
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

9.  Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  I Kurane; D Hebblewaite; W E Brandt; F A Ennis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

Review 10.  Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.

Authors:  Kaitlin Rainwater-Lovett; Isabel Rodriguez-Barraquer; Derek A T Cummings; Justin Lessler
Journal:  BMC Infect Dis       Date:  2012-09-28       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.